Diabetes Medication

Diabetes medication updates, evidence summaries, safety caveats, and patient-friendly treatment context.

1 articlesEvidence-based reviewUpdated regularly

AllMonitoringDiagnosisComplicationsType 1Type 2

Tirzepatide and Heart Outcomes: What SURPASS-CVOT Shows

25th May 202626th March 2026 by Living Diabetes Editorial Team

3 min readReviewed

SURPASS-CVOT tested tirzepatide against dulaglutide in type 2 diabetes and ASCVD. Learn what it showed and what it did not prove.